USD 950

Product Type

Industry Statistics

Release Date

2 August 2021



Release Year


Table of Contents
    Add a header to begin generating the table of contents


    A DNA vaccine is a type of vaccine that transfects a specific antigen-coding DNA sequence onto the cells of an immunized species. DNA vaccines have theoretical advantages over conventional vaccines, including the ability to induce a wider range of types of immune response. The global dna vaccine market is set to grow by US$ 4 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 13.7% during the forecast period, according to data and analytics company StrategyHelix.

    The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for dna vaccine. The global dna vaccine market is segmented on the basis of type, region. By type, it is categorized into research tools, and clinical vaccines. The research tools segment held the largest market share in 2020. By region, the dna vaccine market is divided into North America, Asia Pacific, Europe, and Rest of the World (ROW).

    The report has profiled some of the key players of the market such as Astellas Pharma Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Gilead Sciences Inc., Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi Aventis SA.

    The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the dna vaccine market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

    Report Scope

    Type: research tools, and clinical vaccines
    Region: North America, Asia Pacific, Europe, and Rest of the World (ROW)
    Years Considered: this report covers the period 2017 to 2027

    Key Benefits for Stakeholders

    Get a comprehensive picture of the global dna vaccine market
    Pinpoint growth sectors and trends for investment
    Understand what the future of the global dna vaccine market looks like
    Identify the competitive landscape and window of opportunity

    Table of Contents

    1. Market Definition
    2. Research Methodology
    3. Market Data & Outlook
    3.1 Market Value
    3.2 Market Value Forecast
    4. DNA Vaccine Market by Type
    4.1 Research Tools
    4.2 Clinical Vaccines
    5. DNA Vaccine Market by Region
    5.1 North America
    5.2 Asia Pacific
    5.3 Europe
    5.4 Rest Of The World (Row)
    6. Company Profiles
    6.1 Astellas Pharma Inc.
    6.2 AstraZeneca plc
    6.3 Bristol-Myers Squibb Company
    6.4 Gilead Sciences, Inc.
    6.5 Johnson & Johnson
    6.6 Merck KGaA
    6.7 Novartis AG
    6.8 Pfizer Inc.
    6.9 Sanofi Aventis SA
    7. Appendix
    7.1 About StrategyHelix
    7.2 Disclaimer

    StrategyHelix Black LOGO


    Please fill out our form and we will get back to you.

    Global DNA Vaccine Market 2021

    StrategyHelix Black LOGO


    Custom projects can be researched to match your unique needs.

    Global DNA Vaccine Market 2021